Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report 2021, January 1 – September 30

July - September 2021 Net revenue for the period was SEK 105.6 million (76.2), an increase of 38.6 %. Organic growth was 12.1 %. Adjusted EBITDA for the period was SEK 14.5 million (5.3) EBITDA for the period was SEK 13.3 million (9.4) Adjusted profit/loss for the period was SEK 3.0 million (-1.2) Basic earnings per share for the period amounted to SEK -0.01 (0.02) Orders received for the period totaled SEK 93.7 million (68.0) Cash flow for the period was SEK 23.7 million (-2.9) January - September 2021 Net revenue for the period was SEK 310.9 million (261.7), an

Carbiotix partners with Balsgård Foodtech to accelerate AXOS scale-up

Carbiotix (publ) ("Carbiotix" or "Company") today announces that it will partner with Balsgård Foodtech AB (”Balsgård”) based in Sweden to accelerate the scale-up of its second generation prebiotic soluble fibre CarbiAXOS. This will allow Carbiotix to also accelerate the submission of its first GRAS Self Affirmation dossier by providing the required product samples in Q4.Kristofer Cook, CEO of Carbiotix, comments"I am very pleased to communicate that we will be partnering with Balsgård to accelerate the scale-up of CarbiAXOS. Since our first production site is still under construction and

BioStock: Abliva’s NV354 targets fatal paediatric disease

Earlier this autumn, Abliva announced that NV354, the company’s second candidate within the primary mitochondrial disease space, will progress to clinical phase. NV354 is initially being developed for the fatal Leigh syndrome, a disease that usually debuts before the age of 2 and patients often die before the age of 5. With NV354 about to join Abliva’s leading candidate against primary mitochondrial disease, KL1333, in clinical development, BioStock takes a closer look at the candidate.Read the full article at biostock.se: https://www.biostock.se/en/2021/10/ablivas-nv354-targets-fatal-

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 26th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,097,865 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months

aXichem AB (publ),  a developer of natural analogue industrial compounds, announces, as a follow-up to the previously communicated production status, that the company, through its subcontractors in Europe and Asia, has secured production capacity for volumes up to 100 tons for its salmonella inhibiting and growth promoting feed product, aXiphen-feed, for the upcoming six to nine months. The production is scalable and can be further increased. aXichem delivered 10 tons of aXiphen-feed to its distributor CHR. Olesen at the end of September, after having completed

Modus Therapeutics participates in Småbolagspodden

Stockholm, Wednesday, October 27, 2021. Modus Therapeutics Holding AB ("Modus") announces that the company participates in the latest episode of Småbolagspodden.Modus’ CEO John Öhd and CFO Claes Lindblad are interviewed by Småbolagspodden's Jonathan Furelid. Listen in to the discussions on sepsis, one of the most prevalent death causes globally and Modus' development of sevuparin for sepsis and other patients with high unmet medical needs, as well as a further look into what the future plans for Modus look like. To listen to the episode via Småbolagspodden, click here 

Integrum Partners with Implantcast Benelux to Further Drive Benelux Market for Bone-Anchored Prosthetics

Integrum and Implantcast Benelux have entered into a collaboration focused on the Benelux region. Integrum’s OPRA™ Implant System is an innovative technology aimed at helping improve the quality of life for amputees. Together Integrum and Implantcast Benelux aim to increase adoption for bone-anchored prosthetic technology in key surgical centers in Belgium and the Netherlands. “We are pleased to partner with Implantcast on the Belgian and the Netherland markets, this will increase our presence, and by having a local partner we will strengthen our footprint in the Benelux region“,

Electrolux resolves on repurchase of own shares

The Board of Directors in AB Electrolux has, based on the authorization granted by the Annual General Meeting held on March 25, 2021, resolved to repurchase a maximum of 9,369,172 own series B shares on Nasdaq Stockholm during the period October 28, 2021 up to and including March 25, 2022 for a total maximum amount of SEK 2,800 million.“We are now executing on the next step in optimizing Electrolux capital structure, which was announced in July this year, where we are distributing a larger part of the value created to our shareholders”, says Staffan Bohman, Chairman of the Board of

Interim report January to September 2021

Press release, Sweden, Stockholm, October 27, 2021 Increased net sales and gross margin despite difficult component situation Third quarter 2021 · Net sales increased during the third quarter by 12,7% to 80,0 MSEK (71,0). Currency translations had a negative effect of 0,7 MSEK on net sales. · Adjusted EBITDA decreased during the third quarter by 3,3% to 8,4 MSEK (8,6), corresponding to an adjusted EBITDA margin by 10,4 % (12,2) · Operating profit/loss was 1,7 MSEK (2,7) which correspond to operating margin of 2,1% (3,9) · Profit for the period was 1,7 MSEK (3,3) ·

AcouSort sells additional AcouTrap to South Korean customer

AcouSort has received an order for an AcouTrap system from an existing South Korean customer within the Life Science sector. The customer bought their first AcouTrap in October 2019 and has now decided to purchase a second system. This system will be delivered during Q4 2021.– It feels great to sell an additional system to one of our existing customers. We are very happy that they are pleased with the system, technology and support we have provided and that they see the need for a second system, which will be used within another branch of the organization, says AcouSort’s CEO Torsten

Alfa Laval opens next generation manufacturing site in Italy as part of its Industry 4.0 strategy

Alfa Laval recently opened a new greenfield manufacturing site in San Bonifacio, Italy, for the production of brazed heat exchangers. The new highly advanced facility includes research and customer training areas and will mainly supply heat exchangers to customers in Europe.The factory in Italy, inaugurated in late September, is Alfa Laval’s most modern and sustainable production facility yet, with rooftop solar panels supplying energy. It has a digitalized warehouse management system to oversee the flow of materials and goods, an advanced automated production set-up, an on-site training

First Camp delivering a record-high quarterly result

First Camp, Scandinavia’s largest campsite chain, is delivering a Q3 result that is higher than the same quarter in 2019, that is pre-Covid-19. Total revenues for the quarter were 291.6 MSEK, and Pro-forma adjusted EBITDA 161.4 MSEK, +32.9 MSEK vs Q3 2020 and +28.4 MSEK vs. Q3 2019, excluding effects from acquisitions.”The Scandinavian camping industry has recovered from the Covid-19 pandemic and First Camp has continued to strengthen its market position thanks to further improvements of the guest experience as well as digital development. The entire First Camp team deserves credit for

Interim Report January – September 2021

Highlights for the third quarter · Record sales with year-on-year revenue growth across product segments, despite comparing to a prior year quarter with elevated demand for certain product lines. · In local currencies, sales increased by 10 percent for the third quarter. Reported sales increased by 9 percent to 4,778 MSEK (4,400). · Record operating profit from product segments, in spite of continued ramp-up in spending behind growth opportunities for smokefree products. · In local currencies, operating profit from product segments[1)] increased by 2 percent for the third

2020 Bulkers Ltd. (2020) - Results for the third quarter of 2021

Hamilton, Bermuda, October 27, 2021 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three and nine months ended September 30, 2021. Key events during the third quarter of 2021 · The Company reported net profit of US$21.6 million and EBITDA of US$27.1 million for the third quarter of 2021. · Achieved average time charter equivalent earnings of approximately US$46,000, per day, gross. · The Company declared total cash distributions of US$0.97 per share for the months of July, August and September

Catena’s Nomination Committee in preparation for the 2022 Annual General Meeting

27 October 2021, 8.00 a.m.Catena’s Annual General Meeting on 29 April 2021 decided to appoint a Nomination Committee consisting of representatives of the four largest shareholders and the Chairman. If any one of the four largest shareholders declines to appoint a representative, the Chairman shall urge the next-largest shareholder to appoint a shareholder representative. In accordance with the decision, the members of the Nomination Committee and the shareholders they represent shall be announced as soon as they have been appointed. The Nomination Committee now has the following

Quarterly Report Q3 2021

Strong profitable sales growth Third quarter · Net sales increased by 8% to SEK 23,930 M (22,225), with organic growth of 7% (–5) and acquired net growth of 2% (4) · There was very strong organic sales growth in Americas and Entrance Systems and strong organic sales growth in EMEIA and Global Technologies, but sales decreased in Asia Pacific · An agreement was signed to acquire HHI, a leading provider of security, plumbing, and builders’ hardware products to the North American residential segment. This is an important strategic step in further developing the Group’s

YIT started several residential construction projects in July–September

YIT Corporation Investor News 27 October 2021 at 9:00 a.m.YIT started several residential apartment building projects in Finland and the CEE countries in July–September 2021. The largest projects started during the period were Asunto Oy Kuopion Kruuna, Asunto Oy Vantaan Viikuna, Asunto Oy Espoon Kronos, Asunto Oy Oulun Telegrammi, Asunto Oy Espoon Katajakallio, Asunto Oy Helsingin Friidu, the first phase of the Smartti Mokotów project in Warsaw, Poland, the Zurawie project in Gdańsk, Poland, Magnolia 1 in Bratislava, Slovakia, the VESI project in Prague, Czech Republic and phase II Ranua

Interim report Peab: Profitable growth and high level of orders received

Peab Interim report January – September 2021”Profitable growth and a high level of orders sums up this year's third quarter. Operating margins continue to improve in both the construction contract businesses and housing development, which is the result of several years of committed work”, says Jesper Göransson, President and CEO of Peab. Summary according to segment reporting: July – September 2021 · Net sales SEK 16,121 million (14,837) · Operating profit SEK 1,101 million (844) · Operating margin 6.8 percent (5.7) · Pre-tax profit SEK 1,095 million (824) · Earnings

First Camp delivering a record-high quarterly result

First Camp, Scandinavia’s largest campsite chain, is delivering a Q3 result that is higher than the same quarter in 2019, that is pre-Covid-19. Total revenues for the quarter were 291.6 MSEK, and Pro-forma adjusted EBITDA 161.4 MSEK, +32.9 MSEK vs Q3 2020 and +28.4 MSEK vs. Q3 2019, excluding effects from acquisitions.”The Scandinavian camping industry has recovered from the Covid-19 pandemic and First Camp has continued to strengthen its market position thanks to further improvements of the guest experience as well as digital development. The entire First Camp team deserves credit for

Realhearts CEO invited to speak at EUMS-ISMCS conference

Realheart's CEO Ina Laura Perkins is invited to speak at the joint conference of the European Mechanical Circulatory Support and the International Society for Mechanical Circulatory Support in Hannover, Germany, in December.The EUMS-ISMCS conference runs from the 1st 4th of December and Ina Laura Perkins' presentation on Realheart TAH will take place on December 3rd at 2 PM. ''Germany is one of the most important markets for artificial hearts in Europe and I am grateful to be able to raise awareness of our product and what makes it different from our competitors. Also, the conference

Nomination Committee and AGM 2022

The Nomination Committee of Projektengagemang Sweden AB (publ) has been appointed for the 2022 Annual General Meeting (AGM), which will be held on 5 May, 2022 in Stockholm.In accordance with the decided instructions for the appointment of the Nomination Committee in Projektengagemang, the three largest shareholders in terms of votes have appointed members of the Nomination Committee prior to the 2022 Annual General Meeting, with Per Göransson, Chairman of the Board, convening. Members of the Projektengagemang Nomination Committee are: · Per Göransson, appointed by Projektengagemang

Stille AB: Interim Report Q3 2021

Stille AB (publ) publishes the report for the third quarter. “A quarter with strong growth”, summarizes CEO Hanna Ernestam Wilkman.Stille delivered growth both organically as well as through the acquisition of Swiss company S&T AG. Organic sales grew by 12% compared to the same quarter previous year. “The acquisition of S&T means that business unit Surgical Instruments has doubled in size. The integration of the company is progressing according to plan. Our main focus is to realize identified cross-selling synergies within both product and distribution network”, says CEO Hanna Ernestam

Interim report January – September 2021

• Income amounted to SEK 1,708 million (660). • Net operating income amounted to SEK 1,227 million (500). • Profit from property management amounted to SEK 811 million (335). • Investments in new constructions and refurbishments amounted to SEK 848 million. Project development, including development of building rights, contributed with increases in value of SEK 174 million. Change in property value amounted to SEK 1,514 million (286). • Change in value of financial investments amounted to SEK 605 million (–1,135). • Net profit amounted to SEK 2,525 million (-669), equivalent

Rottneros and KAPSU to jointly develop a new, innovative plastic free beverage solution

Rottneros is partnering with KAPSU, a startup company within the beverage industry, based in Karlstad, to develop and produce a new plastic-free beverage solution. The new container will be made of 100% fiber from local certified forests.The aim is to use their groundbreaking solution to transform the beverage industry through competitive plastic-free solutions, resolving an environmental challenge that people face every day, globally. The solution features a three-part system; a stainless-steel bottle, a container made of 100 percent fiber containing the drink mixes and KAPSU´s own lid

There are no items matching the current filter
There are no more items matching the current filter
Back to top